That depends on who you ask. Texas Gov. Rick Perry believes it was the right thing to do: He delivered an executive order requiring girls entering the sixth grade to be vaccinated with the new human papillomavirus vaccine, Gardasil. Nationwide, 18 states are thinking about following in Texas' footsteps and 28 states have considered related legislation, such as mandating education about or insurance coverage for the drug, according to American Medical News (2/26/2007).
That depends on who you ask. Texas Gov. Rick Perry believes it was the right thing to do: He delivered an executive order requiring girls entering the sixth grade to be vaccinated with the new human papillomavirus vaccine, Gardasil. Nationwide, 18 states are thinking about following in Texas' footsteps and 28 states have considered related legislation, such as mandating education about or insurance coverage for the drug, according to American Medical News (2/26/2007).
However, the Texas House of Representatives has disagreed with Gov. Perry's move and approved a bill to nullify his executive order. Moreover, the Texas Medical Association, the American Academy of Family Physicians, and the American Academy of Pediatrics have asserted that it is too soon to consider state mandates. For one, these groups argue, the long-term safety profile and accessibility issues for the drug have not yet been clarified. In addition, mandating the use of Merck's Gardasil could undermine confidence in the childhood vaccination system as a whole; after all, vocal individuals and groups could use the rush to mandate as additional ammunition to argue against a one-size-fits-all immunization program or one designed to increase profits for drug makers.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More